Disorders of orgasm in women: A literature review of etiology and current treatments

Journal of Sexual Medicine

Volumn 7, Issue 10, 2010, Pages 3254-3268

  IsHak, Waguih William ^a,b,c   Bokarius, Anna ^a   Jeffrey, Jessica K ^b   Davis, Michael C ^b   Bakhta, Yekaterina ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Female Anorgasmia; Female Orgasmic Disorder; Orgasm; Sexual Dysfunction; Woman; Women

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMINEPTINE; ANDROGEN; ANTIDEPRESSANT AGENT; BREMELANOTIDE; CABERGOLINE; ESTROGEN; ESTROGEN DERIVATIVE; FLUOXETINE; FLUVOXAMINE; HERBACEOUS AGENT; METHYLTESTOSTERONE; MIANSERIN; MIDODRINE; MOCLOBEMIDE; MOOD STABILIZER; NEUROLEPTIC AGENT; OXYTOCIN; PAROXETINE; PLACEBO; PROGESTERONE DERIVATIVE; PROSTAGLANDIN E1; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TESTOSTERONE; TIBOLONE; YOHIMBINE;

ANORGASMIA; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EJACULATION DISORDER; EMOTIONALITY; ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; FIBROMYALGIA; FLUSHING; HUMAN; HYPOGONADISM; LIBIDO DISORDER; NAUSEA; NONHUMAN; ORGASM DISORDER; PATHOPHYSIOLOGY; PELVIC ORGAN PROLAPSE; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; SEXUAL ABUSE; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SIDE EFFECT; SOCIAL BELIEF; SOMNOLENCE; UNSPECIFIED SIDE EFFECT;

EID: 77957370122     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01928.x     Document Type: Review

References (104)

1. Meston CM, Hull E, Levin RJ, Sipski M. Disorders of orgasm in women. J Sex Med 2004, 1:66-8.
2. Harris JM, Cherkas LF, Kato BS, Heiman JR, Spector TD. Normal variations in personality are associated with coital orgasmic infrequency in heterosexual women: A population-based study. J Sex Med 2008, 5:1177-83.
3. Redelman M. A general look at female orgasm and anorgasmia. Sex Health 2006, 3:143-53.
4. Lavie-Ajayi M, Joffe H. Social representations of female orgasm. J Health Psychol 2009, 14:98-107.
5. Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Association, American Psychiatric Association, Task Force on DSM-IV, 4th, edition, Washington, DC, American Psychiatric Association
6. Proposed changes and draft diagnostic criteria for DSM-5. 2010, http://www.dsm5.org, American Psychiatric Association, Available at: (accessed April 15, 2010)
7. Graham CA. The DSM diagnostic criteria for female orgasmic disorder. Arch Sex Behav 2010, 39:256-70.
8. IsHak WW. The guidebook of sexual medicine 2007, Beverly Hills, A&W Publishing Group
9. Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: A case-control study. I. Frequency and comparison of groups. Mult Scler 1999, 5:418-27.
10. Lew-Starowicz M, Gellert R. The sexuality and quality of life of hemodialyzed patients-ASED multicenter study. J Sex Med 2009, 6:1062-71.
11. Diemont WL, Vruggink PA, Meuleman EJ, Doesburg WH, Lemmens WA, Berden JH. Sexual dysfunction after renal replacement therapy. Am J Kidney Dis 2000, 35:845-51.
12. Kalichman L. Association between fibromyalgia and sexual dysfunction in women. Clin Rheumatol 2009, 28:365-9.
13. Ghoniem GM, Davila GW. Practical guide to female pelvic medicine 2006, London; New York, Taylor & Francis
14. Amarenco G, Le Cocquen A, Bosc S. Stress urinary incontinence and genito-sexual conditions. Study of 35 cases. Prog Urol 1996, 6:913-9.
15. Handa VL, Harvey L, Cundiff GW, Siddique SA, Kjerulff KH. Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 2004, 191:751-6.
16. Stimmel GL, Gutierrez MA. Sexual dysfunction and psychotropic medications. CNS Spectr 2006, 11:24-30.
17. Montejo-Gonzalez AL, Llorca G, Izquierdo JA. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997, 23:176-94.
18. Galanter M. Alcoholism and women 1995, New York, Plenum Press
19. Berman JR, Berman L, Goldstein I. Female sexual dysfunction: Incidence, pathophysiology, evaluation, and treatment options. Urology 1999, 54:385-91.
20. Basson R. Women's sexuality and sexual dysfunction. Danforth's Obstetrics and Gynecology 2008, 742. Gibbs RS. In, 10th ed., Philadelphia, Pa., Lippincott Williams & Wilkins
21. Graziottin A. The biological basis of female sexuality. Int Clin Psychopharmacol 1998, 13(6):S15-22. suppl
22. Nicholas A, Brody S, de Sutter P, de Carufel F. A woman's history of vaginal orgasm is discernible from her walk. J Sex Med 2008, 5:2119-24.
23. Dunn KM, Cherkas LF, Spector TD. Genetic influences on variation in female orgasmic function: A twin study. Biol Lett 2005, 1:260-3.
24. Birnbaum GE. The meaning of heterosexual intercourse among women with female orgasmic disorder. Arch Sex Behav 2003, 32:61-71.
25. Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology 2009, 34:1819-28.
26. Ackard DM, Kearney-Cooke A, Peterson CB. Effect of body image and self-image on women's sexual behaviors. Int J Eat Disord 2000, 28:422-9.
27. Berman L, Berman J, Miles M, Pollets D, Powell JA. Genital self-image as a component of sexual health: Relationship between genital self-image, female sexual function, and quality of life measures. J Sex Marital Ther 2003, 29(1):11-21. suppl
28. Witting K, Santtila P, Rijsdijk F. Correlated genetic and non-shared environmental influences account for the co-morbidity between female sexual dysfunctions. Psychol Med 2009, 39:115-27.
29. Meston CM, Gorzalka BB. Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women. J Abnorm Psychol 1996, 105:582-91.
30. Kelly MP, Strassberg DS, Kircher JR. Attitudinal and experiential correlates of anorgasmia. Arch Sex Behav 1990, 19:165-77.
31. Komisaruk BR, Whipple B, Crawford A, Liu WC, Kalnin A, Mosier K. Brain activation during vaginocervical self-stimulation and orgasm in women with complete spinal cord injury: fMRI evidence of mediation by the vagus nerves. Brain Res 2004, 1024:77-88.
32. Wade LD, Kremer EC, Brown J. The incidental orgasm: The presence of clitoral knowledge and the absence of orgasm for women. Women Health 2005, 42:117-38.
33. Bartoi AG, Kinder BN. Effects of child and adult sexual abuse on adult sexuality. J Sex Marital Ther 1998, 24:75-90.
34. Burri AV, Cherkas LM, Spector TD. Emotional intelligence and its association with orgasmic frequency in women. J Sex Med 2009, 6:1930-7.
35. Vaillant GE. Natural history of male psychological health: V. The relation of choice of ego mechanisms of defense to adult adjustment. Arch Gen Psychiatry 1976, 33:535-45.
36. Vaillant GE, Vaillant CO. Natural history of male psychological health, XII: A 45-year study of predictors of successful aging at age 65. Am J Psychiatry 1990, 147:31-7.
37. Brody S, Costa RM. Vaginal orgasm is associated with less use of immature psychological defense mechanisms. J Sex Med 2008, 5:1167-76.
38. Costa RM, Brody S. Immature defense mechanisms are associated with lesser vaginal orgasm consistency and greater alcohol consumption before sex. J Sex Med 2010, 7:775-86.
39. Meston CM, Levin RJ, Sipski ML, Hull EM, Heiman JR. Women's orgasm. Annu Rev Sex Res 2004, 15:173-257.
40. Woo JS, Brotto LA. Age of first sexual intercourse and acculturation: Effects on adult sexual responding. J Sex Med 2008, 5:571-82.
41. Brody S, Laan E, Van Lunsen RHW. Concordance between women's physiological and subjective sexual arousal is associated with consistency of orgasm during intercourse but not other sexual behavior. J Sex Marital Ther 2003, 29:15-23.
42. Brody S. Intercourse orgasm consistency, concordance of women's genital and subjective sexual arousal, and erotic stimulus presentation sequence. J Sex Marital Ther 2007, 33:31-9.
43. Komisaruk BR, Whipple B. Love as sensory stimulation: Physiological consequences of its deprivation and expression. Psychoneuroendocrinology 1998, 23:927-44.
44. Komisaruk BR, Whipple B. Functional MRI of the brain during orgasm in women. Annu Rev Sex Res 2005, 16:62-86.
45. Brody S. The relative health benefits of different sexual activities. J Sex Med 2010, 7:1336-61.
46. Gravina GL, Brandetti F, Martini P. Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm. J Sex Med 2008, 5:610-8.
47. Simons JS, Carey MP. Prevalence of sexual dysfunctions: Results from a decade of research. Arch Sex Behav 2001, 30:177-219.
48. Read S, King M, Watson J. Sexual dysfunction in primary medical care: Prevalence, characteristics and detection by the general practitioner. J Public Health Med 1997, 19:387-91.
49. Rothschild AJ. New directions in the treatment of antidepressant-induced sexual dysfunction. Clin Ther 2000, 22(A):A42-57. suppl, discussion A58-61
50. Kingsberg S, Althof SE. Evaluation and treatment of female sexual disorders. Int Urogynecol J Pelvic Floor Dysfunct 2009, 20(1):S33-43. suppl
51. Basson R. Androgen replacement for women. Can Fam Physician 1999, 45:2100-7.
52. Davis SR, van der Mooren MJ, van Lunsen RH. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Menopause 2006, 13:387-96.
53. Davis SR, Moreau M, Kroll R. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008, 359:2005-17.
54. Nathorst-Boos J, Floter A, Jarkander-Rolff M, Carlstrom K, Schoultz B. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido-Effects on sexuality and psychological general well-being. Maturitas 2006, 53:11-8.
55. Shifren JL, Braunstein GD, Simon JA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000, 343:682-8.
56. Braunstein GD, Sundwall DA, Katz M. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch Intern Med 2005, 165:1582-9.
57. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995, 21:227-36.
58. Penteado SR, Fonseca AM, Bagnoli VR, Abdo CH, Junior JM, Baracat EC. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women. Climacteric 2008, 11:17-25.
59. Kamenov ZA, Todorova MK, Christov VG. Effect of tibolone on sexual function in late postmenopausal women. Folia Med (Plovdiv) 2007, 49:41-8.
60. Uygur D, Yesildaglar N, Erkaya S. Effect on sexual life-A comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate. Gynecol Endocrinol 2005, 20:209-12.
61. Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy. Climacteric 2001, 4:314-9.
62. Caruso S, Agnello C, Intelisano G, Farina M, Di Mari L, Cianci A. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception 2004, 69:237-40.
63. Cayan F, Dilek U, Pata O, Dilek S. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women. J Sex Med 2008, 5:132-8.
64. Long CY, Liu CM, Hsu SC, Wu CH, Wang CL, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 2006, 13:737-43.
65. Schmidt PJ, Steinberg EM, Negro PP, Haq N, Gibson C, Rubinow DR. Pharmacologically induced hypogonadism and sexual function in healthy young women and men. Neuropsychopharmacology 2009, 34:565-76.
66. Michelson D, Bancroft J, Targum S, Kim Y, Tepner R. Female sexual dysfunction associated with antidepressant administration: A randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry 2000, 157:239-43.
67. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004, 65:62-7.
68. Masand PS, Ashton AK, Gupta S, Frank B. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: A randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001, 158:805-7.
69. Modell JG, May RS, Katholi CR. Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: A pilot study. J Sex Marital Ther 2000, 26:231-40.
70. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004, 24:339-42.
71. Stimmel GL, Gutierrez MA. Pharmacologic treatment strategies for sexual dysfunction in patients with epilepsy and depression. CNS Spectr 2006, 11:31-7.
72. Melmed S, IsHak WW, Berman D. Use of cabergoline for the treatment of anorgasmia or delayed orgasm. 158th annual meeting of the American Psychiatric Association. Atlanta; May 21-26, 2005
73. Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: A randomised controlled trial. BJOG 2003, 110:1014-24.
74. Caruso S, Intelisano G, Lupo L, Agnello C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: A double-blind, cross-over, placebo-controlled study. BJOG 2001, 108:623-8.
75. Nurnberg HG, Hensley PL, Lauriello J, Parker LM, Keith SJ. Sildenafil for women patients with antidepressant-induced sexual dysfunction. Psychiatr Serv 1999, 50:1076-8.
76. Kaplan SA, Reis RB, Kohn IJ. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999, 53:481-6.
77. Jonas D, Linzbach P, Weber W. The use of Midodrin in the treatment of ejaculation disorders following retroperitoneal lymphadenectomy. Eur Urol 1979, 5:184-7.
78. Soler JM, Previnaire JG, Plante P, Denys P, Chartier-Kastler E. Midodrine improves orgasm in spinal cord-injured men: The effects of autonomic stimulation. J Sex Med 2008, 5:2935-41.
79. Courtois F, Charvier K, Leriche A. Perceived physiological and orgasmic sensations at ejaculation in spinal cord injured men. J Sex Med 2008, 5:2419-30.
80. Ishak WW, Berman DS, Peters A. Male anorgasmia treated with oxytocin. J Sex Med 2008, 5:1022-4.
81. Wilson LA, Wayman CP, Jackson VM. Neuropeptide modulation of a lumbar spinal reflex: Potential implications for female sexual function. J Sex Med 2009, 6:947-57.
82. Safarinejad MR. Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: A double-blind placebo-controlled, fixed dose, randomized study. J Sex Med 2008, 5:887-97.
83. Ferguson DM, Steidle CP, Singh GS, Alexander JS, Weihmiller MK, Crosby MG. Randomized, placebo-controlled, double blind, crossover design trial of the efficacy and safety of Zestra for Women in women with and without female sexual arousal disorder. J Sex Marital Ther 2003, 29(1):33-44. suppl
84. Ito TY, Polan ML, Whipple B, Trant AS. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status. J Sex Marital Ther 2006, 32:369-78.
85. Kielbasa LA, Daniel KL. Topical alprostadil treatment of female sexual arousal disorder. Ann Pharmacother 2006, 40:1369-76.
86. Ito TY, Trant AS, Polan ML. A double-blind placebo-controlled study of ArginMax, a nutritional supplement for enhancement of female sexual function. J Sex Marital Ther 2001, 27:541-9.
87. Huang A, Yaffe K, Vittinghoff E. The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women. Am J Obstet Gynecol 2008, 198:265e1-7.
88. Meston CM, Rellini AH, Telch MJ. Short- and long-term effects of Ginkgo biloba extract on sexual dysfunction in women. Arch Sex Behav 2008, 37:530-47.
89. Aizenberg D, Naor S, Zemishlany Z, Weizman A. The serotonin antagonist mianserin for treatment of serotonin reuptake inhibitor-induced sexual dysfunction in women: An open-label add-on study. Clin Neuropharmacol 1999, 22:347-50.
90. Keller Ashton A, Hamer R, Rosen RC. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997, 23:165-75.
91. DeUgarte CM, Berman L, Berman J. Female sexual dysfunction-From diagnosis to treatment. Sex Reproduction Menopause 2004, 2:139-45.
92. Leff JJ, Israel M. The relationship between mode of female masturbation and achievement of orgasm in coitus. Arch Sex Behav 1983, 12:227-36.
93. Struck P, Ventegodt S. Clinical holistic medicine: Teaching orgasm for females with chronic anorgasmia using the Betty Dodson method. Sci World J 2008, 8:883-95.
94. McCabe MP. Anorgasmia in women. J Fam Psychother 2009, 20:177-97.
95. Pierce AP. The coital alignment technique (CAT): An overview of studies. J Sex Marital Ther 2000, 26:257-68.
96. Hurlbert DF, Apt C. The coital alignment technique and directed masturbation: A comparative study on female orgasm. J Sex Marital Ther 1995, 21:21-9.
97. Brody S, Weiss P. Vaginal orgasm is associated with vaginal (not clitoral) sex education, focusing mental attention on vaginal sensations, intercourse duration, and a preference for a longer penis. J Sex Med 2010, Sep 1 [Epub ahead of print]. doi: 10.1111/j.1743-6109.2009.01469.x
98. Weiss P, Brody S. Women's partnered orgasm consistency is associated with greater duration of penile-vaginal intercourse but not of foreplay. J Sex Med 2009, 6:135-41.
99. Kegel AH. Sexual functions of the pubococcygeus muscle. West J Surg Obstet Gynecol 1952, 60:521-4.
100. Graber B, Kline-Graber G. Female orgasm: Role of pubococcygeus muscle. J Clin Psychiatry 1979, 40:348-51.
101. Roughan PA, Kunst L. Do pelvic floor exercises really improve orgasmic potential? J Sex Marital Ther 1981, 7:223-9.
102. Trudel G, Saint-Laurent S. A comparison between the effects of Kegel's exercises and a combination of sexual awareness relaxation and breathing on situational orgasmic dysfunction in women. J Sex Marital Ther 1983, 9:204-9.
103. Chambless DL, Sultan FE, Stern TE, O'Neill C, Garrison S, Jackson A. Effect of pubococcygeal exercise on coital orgasm in women. J Consult Clin Psychol 1984, 52:114-8.
104. Rivalta M, Sighinolfi MC, De Stefani S. Biofeedback, electrical stimulation, pelvic floor muscle exercises, and vaginal cones: A combined rehabilitative approach for sexual dysfunction associated with urinary incontinence. J Sex Med 2009, 6:1674-7.